Your browser doesn't support javascript.
loading
Partial MCT1 invalidation protects against diet-induced non-alcoholic fatty liver disease and the associated brain dysfunction.
Hadjihambi, Anna; Konstantinou, Christos; Klohs, Jan; Monsorno, Katia; Le Guennec, Adrien; Donnelly, Chris; Cox, I Jane; Kusumbe, Anjali; Hosford, Patrick S; Soffientini, Ugo; Lecca, Salvatore; Mameli, Manuel; Jalan, Rajiv; Paolicelli, Rosa Chiara; Pellerin, Luc.
Afiliación
  • Hadjihambi A; Department of Biomedical Sciences, University of Lausanne, Lausanne, Switzerland; The Roger Williams Institute of Hepatology London, Foundation for Liver Research, London, UK; Faculty of Life Sciences and Medicine, King's College London, London, UK. Electronic address: a.hadjichambi@researchinliver.
  • Konstantinou C; The Roger Williams Institute of Hepatology London, Foundation for Liver Research, London, UK; Faculty of Life Sciences and Medicine, King's College London, London, UK.
  • Klohs J; Institute for Biomedical Engineering, University of Zurich and ETH Zurich, Zurich, Switzerland; Neuroscience Centre Zurich, University of Zurich and ETH Zurich, Zurich, Switzerland.
  • Monsorno K; Department of Biomedical Sciences, University of Lausanne, Lausanne, Switzerland.
  • Le Guennec A; NMR Facility, Guy's Campus, King's College London, London, UK.
  • Donnelly C; Department of Biomedical Sciences, University of Lausanne, Lausanne, Switzerland; Institute of Sports Science, University of Lausanne, Lausanne, Switzerland.
  • Cox IJ; The Roger Williams Institute of Hepatology London, Foundation for Liver Research, London, UK; Faculty of Life Sciences and Medicine, King's College London, London, UK.
  • Kusumbe A; Tissue and Tumor Microenvironments Group, MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
  • Hosford PS; Centre for Cardiovascular and Metabolic Neuroscience, Neuroscience, Physiology and Pharmacology, University College London, London, UK.
  • Soffientini U; The Roger Williams Institute of Hepatology London, Foundation for Liver Research, London, UK; Faculty of Life Sciences and Medicine, King's College London, London, UK.
  • Lecca S; The Department of Fundamental Neuroscience, University of Lausanne, Lausanne, Switzerland.
  • Mameli M; The Department of Fundamental Neuroscience, University of Lausanne, Lausanne, Switzerland; Inserm, UMR-S 839, Paris, France.
  • Jalan R; Institute for Liver and Digestive Health, Division of Medicine, UCL Medical School, Royal Free Hospital, University College London, London, UK.
  • Paolicelli RC; Department of Biomedical Sciences, University of Lausanne, Lausanne, Switzerland.
  • Pellerin L; Department of Biomedical Sciences, University of Lausanne, Lausanne, Switzerland; Inserm U1313, Université de Poitiers et CHU de Poitiers, France. Electronic address: luc.pellerin@univ-poitiers.fr.
J Hepatol ; 78(1): 180-190, 2023 01.
Article en En | MEDLINE | ID: mdl-35995127
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Encefalopatías / Enfermedad del Hígado Graso no Alcohólico Tipo de estudio: Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Animals Idioma: En Revista: J Hepatol Asunto de la revista: GASTROENTEROLOGIA Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Encefalopatías / Enfermedad del Hígado Graso no Alcohólico Tipo de estudio: Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Animals Idioma: En Revista: J Hepatol Asunto de la revista: GASTROENTEROLOGIA Año: 2023 Tipo del documento: Article